Online from: 1989
Subject Area: International Business
Options: To add Favourites and Table of Contents Alerts please take a Emerald profile
|Title:||A new product launch strategy (NPLS) model for pharmaceutical companies|
|Author(s):||Peter Trim, (Department of Management, Birkbeck College, University of London, London, UK), Hao Pan, (Orion Pharma, Newbury, UK)|
|Citation:||Peter Trim, Hao Pan, (2005) "A new product launch strategy (NPLS) model for pharmaceutical companies", European Business Review, Vol. 17 Iss: 4, pp.325 - 339|
|Keywords:||Decision making, Marketing models, Pharmaceuticals industry, Product launch|
|Article type:||Research paper|
|DOI:||10.1108/09555340510607370 (Permanent URL)|
|Publisher:||Emerald Group Publishing Limited|
Purpose – The purpose of this paper is to make explicit how marketers employed in the pharmaceutical sector can ensure that the company is positioned in the industry as a result of a sustainable competitive advantage being achieved. Various factors are highlighted, including high research and development costs, stringent government regulations and cultural factors such as religion.
Design/methodology/approach – The new product launch strategy model outlined in this paper was developed from both secondary and primary sources. A literature review was undertaken, a number of in-depth personal interviews and a focus group session were conducted, which involved managers within a pharmaceutical company. The research strategy encompassed the case study method and the NPLS model was validated and can be viewed as generalisable.
Findings – It is clear from the research undertaken that some marketing models are viewed as being too complex; however, it is generally appreciated that marketing models can be used to interpret complex relationships that are evident in a marketing system.
Research limitations/implications – Two weaknesses associated with the model were identified. First, the assumption that there was a one-way relationship between the strategic launch decisions and the tactical launch decisions and, second, a feedback mechanism was absent that would provide users of the model with a means for evaluating their decisions and identifying alternative strategies and tactics. The model was amended and a feedback mechanism was introduced.
Practical implications – The NPLS model can be used by marketing practitioners to enhance communication between corporate level staff and subsidiary level staff, and can be used to implement and/or facilitate the strategic marketing concept within a pharmaceutical company. The model can also be used to focus attention on risk reduction/elimination associated with market entry.
Originality/value – The NPLS model is an addition to marketing knowledge and can assist marketing academics and researchers to understand better how marketing models can be constructed and implemented. The model can also be used by marketing practitioners employed by pharmaceutical companies to make tactical and strategic decisions; to evaluate a new product launch strategy; and to devise international marketing entry plans and strategies.
Existing customers: login
to access this document
To purchase this item please login or register.
Complete and print this form to request this document from your librarian